ETV5 reduces androgen receptor expression and induces neural stem–like properties during neuroendocrine prostate cancer development

Proceedings of the National Academy of Sciences, Volume 122, Issue 12, March 2025. <br/>SignificanceProstate cancer typically relies on male hormones for growth; however, prolonged hormone therapy can lead to a more aggressive form known as neuroendocrine prostate cancer (NEPC), which is resistant to treatment. This study identifies E26 …



Source link